XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities    
Net loss $ (16,474,688) $ (16,334,615)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 3,663,953 2,742,162
Bad debt expense 492,906 927,847
Gain on debt extinguishment (1,205,195) (24,925)
Equity based compensation expense 4,106,040 5,400,975
Recognized loss on marketable securities 0 1,424
Loan principal paid directly through grant 0 (2,992)
Amortization of debt discount and debt costs 499,031 2,503,160
Warrant modification expense 152,244 12,624
Initial derivative expense 0 3,585,983
Impairment expense 4,420,539 2,530,325
Change in fair value of derivative liability 0 (7,315,580)
Factoring discount fee and interest 179,303 0
Gain on sale of intangible assets (250,000) 0
Change in fair value of earn-out liability 26,604 35,294
Changes in assets and liabilities:    
Increase in accounts receivable (1,492,093) (4,690,668)
Decrease (increase) in accounts receivable - related parties 49,033 (7,909)
Decrease (increase) in prepaid expenses and other current assets 253,149 (74,742)
(Decrease) increase in accounts payable and accrued liabilities (594,967) 1,991,446
Decrease in accounts payable and accrued liabilities - related parties (163,672) (746,756)
Decrease in deferred payroll taxes (79,244) (77,304)
Increase in other liabilities 0 2,840
(Decrease) increase in deferred revenue (531,231) 525,767
Net cash used in operating activities (6,948,288) (9,015,644)
Cash Flows From Investing Activities:    
Capitalized software development costs (1,325,491) 0
Cash paid for acquisitions; net of cash acquired 0 (2,238,958)
Proceeds from sale of intangible assets 1,050,000 0
Purchase of property and equipment (74,606) 0
Net cash used in investing activities (350,097) (2,238,958)
Cash Flows From Financing Activities:    
Proceeds from loans 4,077,127 250,000
Proceeds from convertible notes 0 2,153,200
Deferred offering costs 0 78,038
Repayments of loans (2,013,661) (723,611)
Repayments of sale of future revenues 0 (10,904)
Proceeds from factoring agreement 7,303,537 0
Repayments of factoring agreement (3,705,876) 0
Proceeds from common shares and warrants 0 13,800,000
Offering Costs 0 (1,651,889)
Net cash provided by financing activities 5,661,127 13,738,758
Net increase (decrease) in cash (1,637,258) 2,484,156
Cash, beginning of year 2,584,062 99,906
Cash, end of year 946,804 2,584,062
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 256,648 240,980
Cash paid during the year for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Accounts receivable owed under factoring agreement collected directly by factor 3,495,683 0
Purchase price measurement period adjustment to goodwill and accounts receivable 35,644 0
Common shares issued to settle accrued liability 409,036 0
Original issue discount deducted from convertible note proceeds 0 342,554
Debt discount on warrants granted with notes 1,632,842 0
Debt costs deducted from convertible note proceeds 0 334,800
Notes and accrued interest converted to common stock 0 4,557,718
Notes payable and accrued interest exchanged for debentures 0 252,430
Accounts payable paid with common stock 0 140,000
Accrued compensation paid with common stock 0 16,425
Warrant derivative liability extinguished 0 10,182,476
Write off of right-of-use asset and lease liability 0 103,953
Deferred offering costs charged to additional paid-in capital 0 78,038
Common stock issued/to be issued for asset acquisitions 0 11,340,284
Earn-out liability consideration for acquisition 0 543,297
Loans issued as consideration for acquisitions 0 4,750,000
Shares issued for Upsider earn-out liability 0 1,394,768
Warrant derivative liability at inception recorded as debt discount 0 2,374,076
Prepayment of shares issued for services $ 0 $ 237,382